THE SOCIETAL IMPACT OF LENALIDOMIDE IN THE TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA IN GERMANY

被引：0
|
作者：
Hofmann, S. [1 ]
Seddik, A. [1 ]
机构：
[1] WifOR, Darmstadt, HE, Germany
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN216
引用
收藏
页码：S478 / S478
页数：1
相关论文
共 50 条
  • [1] Lenalidomide in the treatment of multiple myeloma
    Rao, Kamakshi V.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (17) : 1799 - 1807
  • [2] How lenalidomide is changing the treatment of patients with multiple myeloma
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Niesvizky, Ruben
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2013, 88 : S23 - S35
  • [3] Repeated Lenalidomide Treatment in Patients With Relapsed Multiple Myeloma
    Stork, Martin
    Pour, Ludek
    Adam, Zdenek
    Krejci, Marta
    Sandecka, Viera
    Vaculova, Jitka
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E56 - E57
  • [4] A budget impact analysis of lenalidomide in multiple myeloma Egyptian patients
    Elsisi, Gihan Hamdy
    Carapinha, Joao L.
    Afify, Rania
    Abd Elmoty, Mohamed
    Khalaf, Mohamed
    JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (10) : 1168 - 1175
  • [5] Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Kuo, Alyce M.
    Hassoun, Hani
    Shah, Urvi
    Gordon, Allison
    Hollmann, Travis J.
    Landau, Heather J.
    Lezcano, Cecilia
    Mailankody, Sham
    Tan, Carlyn C.
    Lesokhin, Alexander M.
    Markova, Alina
    LEUKEMIA & LYMPHOMA, 2022, 63 (09) : 2233 - 2237
  • [6] THE IMPACT OF TREATMENT PERSISTENCE WITH LENALIDOMIDE FOR THE TREATMENT OF MULTIPLE MYELOMA (MM) ON DISEASE CONTROL
    Henk, J.
    Kaura, S.
    Khan, Z.
    Burton, T.
    Teitelbaum, A.
    HAEMATOLOGICA, 2012, 97 : 441 - 442
  • [7] Lenalidomide in the treatment of multiple myeloma: a review
    Armoiry, X.
    Aulagner, G.
    Facon, T.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2008, 33 (03) : 219 - 226
  • [8] Continued treatment with lenalidomide in multiple myeloma
    Sánchez J.M.
    Advances in Therapy, 2011, 28 (Suppl 8) : 1 - 13
  • [9] Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment
    Dimopoulos, Meletios A.
    Terpos, Evangelos
    Goldschmidt, Hartmut
    Alegre, Adrian
    Mark, Tomer
    Niesvizky, Ruben
    CANCER TREATMENT REVIEWS, 2012, 38 (08) : 1012 - 1019
  • [10] Thalidomide and lenalidomide in the treatment of multiple myeloma
    Kumar, Shaji
    Rajkumar, S. Vincent
    EUROPEAN JOURNAL OF CANCER, 2006, 42 (11) : 1612 - 1622
12345